What they were paid
Esperion Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $95,000 | $28,730 | $28,474 | — | $152,204 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Esperion Therapeutics, Inc. DEF 14A filed April 16, 2026, accession 0001628280-26-025499, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Esperion Therapeutics pays directors a $35,000 cash retainer.
Committees
FY2025 · as the proxy prints themAudit · Compliance (Chair)
The rest of the Esperion Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Craig Thompson | Independent Director | $47,499 |
| Jay P. Shepard | Independent Director | $127,708 |
| Robert E. Hoffman | Independent Director | $86,378 |
| Seth H.Z. Fischer | Independent Director | $132,708 |
| Sheldon L. Koenig | Director | $0 |
| Stephen Rocamboli | Independent Director | $124,704 |
| Tracy M. Woody | Independent Director | $129,206 |
The full Esperion Therapeutics compensation record
free company briefThis page is one director within Esperion Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat